Remove Medicine Remove Pharmaceutical research Remove Prospecting
article thumbnail

Optimising drug release of personalised 3D printed tablets

European Pharmaceutical Review

“The ability to predict dissolution curves based on tablet structure, and vice versa, holds promising prospects for tablet design and the application of 3D printing in pharmaceuticals”, the authors explained. their approach in the study addresses “diverse pharmaceutical manufacturing demands”.

article thumbnail

Dawn of a new indication: how to study drugs for aging 

Pharmaceutical Technology

Dr. Nir Barzilai, the scientific director for TAME and the director of the Institute for Aging Research at the Albert Einstein College of Medicine, New York, says projects like the TAME trial could be what regulators need to see to prove the validity of clinical trials in this area.

FDA 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

And so pharma profiteers again

World of DTC Marketing

BMS believes they price our medicines based on the value they deliver,” but physicians say the price is too high. One of the biggest problems with a system that directs medical research towards profits rather than needs is that R&D funding is channelled to those products that can make pharma companies the most money.

Pharma 147
article thumbnail

Primate models in pharma: What the future holds

Pharmaceutical Technology

Pharmaceutical research has long relied on non-human primate models for early-stage discoveries, but their use continues to cause controversy. While multiple testing labs that use non-human primates for research were contacted for this article, all declined to comment amidst the most recent news coverage.

Pharma 98